Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10149
mi
from
New Braunfels, TX
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10149
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site
mi
from
San Antonio, TX
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 10103
mi
from
Waco, TX
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 10103
mi
from
Waco, TX
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site
mi
from
Huntington Beach, CA
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site 021
mi
from
Jacksonville, FL
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site 021
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated:  2/5/2016
Teva Investigational Site
mi
from
Medford, OR
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® HFA in Pediatric Patients With Persistent Asthma
Status: Enrolling
Updated: 2/5/2016
Teva Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Usage, Usability & Effect on Adherence and Clinical Outcomes of Text Message Reminders for Adolescents With Asthma
Study of the Usage, Usability, Acceptability, and Effect on Adherence and Clinical Outcomes of a Web Based Text Messaging System for Adolescents With Asthma- Phase 2
Status: Enrolling
Updated:  2/11/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Usage, Usability & Effect on Adherence and Clinical Outcomes of Text Message Reminders for Adolescents With Asthma
Study of the Usage, Usability, Acceptability, and Effect on Adherence and Clinical Outcomes of a Web Based Text Messaging System for Adolescents With Asthma- Phase 2
Status: Enrolling
Updated: 2/11/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
West Coast Clinical Trials
mi
from
Costa Mesa, CA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
West Coast Clinical Trials
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Southern California Institute for Respiratory Diseases, Inc.
mi
from
Los Angeles, CA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Southern California Institute for Respiratory Diseases, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
CHOC PSF, AMD, Division of Allergy, Asthma and Immunology
mi
from
Orange, CA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
CHOC PSF, AMD, Division of Allergy, Asthma and Immunology
mi
from
Orange, CA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Allergy & Asthma Associates of Santa Clara Valley Research Center
mi
from
San Jose, CA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Allergy & Asthma Associates of Santa Clara Valley Research Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Bensch Research Associates
mi
from
Stockton, CA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Bensch Research Associates
mi
from
Stockton, CA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Colorado Allergy and Asthma Centers, PC
mi
from
Denver, CO
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Colorado Allergy and Asthma Centers, PC
mi
from
Denver, CO
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Rocky Mountain Center for Clinical Research
mi
from
Wheat Ridge, CO
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Rocky Mountain Center for Clinical Research
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Iowa Clinical Research Corportation
mi
from
Iowa City, IA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Iowa Clinical Research Corportation
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Northeast Medical Research Associates, Inc.
mi
from
North Dartmouth, MA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Northeast Medical Research Associates, Inc.
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Clinical Research Group of Montana
mi
from
Bozeman, MT
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Clinical Research Group of Montana
mi
from
Bozeman, MT
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
The Asthma & Allergy Center, PC
mi
from
Bellevue, NE
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
The Asthma & Allergy Center, PC
mi
from
Bellevue, NE
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Princeton Center for Clinical Research
mi
from
Skillman, NJ
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Princeton Center for Clinical Research
mi
from
Skillman, NJ
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
New Horiznons Clinical Research
mi
from
Cincinnati, OH
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
New Horiznons Clinical Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Integrated Medical Research, PC
mi
from
Ashland, OR
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Integrated Medical Research, PC
mi
from
Ashland, OR
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Allergy and Asthma Research Group
mi
from
Eugene, OR
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Allergy and Asthma Research Group
mi
from
Eugene, OR
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Clinical Research Institute of Southern Oregon, PC
mi
from
Medford, OR
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Clinical Research Institute of Southern Oregon, PC
mi
from
Medford, OR
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Allergy Associates Research Center
mi
from
Portland, OR
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Allergy Associates Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
National Allergy, Asthma and Urticaria Centers of Charleston, P.A.
mi
from
North Charleston, SC
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
National Allergy, Asthma and Urticaria Centers of Charleston, P.A.
mi
from
North Charleston, SC
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Western Sky Medical Research
mi
from
El Paso, TX
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Western Sky Medical Research
mi
from
El Paso, TX
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Central Texas Health Research
mi
from
New Braunfels, TX
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Central Texas Health Research
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Allergy Partners, PA/VA Adult and Pediatric Allergy and Asthma, P.C.
mi
from
Richmond, VA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Allergy Partners, PA/VA Adult and Pediatric Allergy and Asthma, P.C.
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
ASTHMA, Inc.
mi
from
Seattle, WA
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
ASTHMA, Inc.
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
Clinical Research Institute Inc
mi
from
Plymouth, MN
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
Clinical Research Institute Inc
mi
from
Plymouth, MN
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
The Clinical Research Center, L.L.C.
mi
from
St. Louis, MO
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
The Clinical Research Center, L.L.C.
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated:  2/11/2016
North Carolina Clinical Research
mi
from
Raleigh, NC
Safety Study in Adolescent and Adult Patients With Asthma
A 3-MONTH SAFETY EVALUATION EXTENSION TO THE 12-WEEK E004-C STUDY IN ASTHMA PATIENTS (A Double Blinded, Placebo-Controlled, Parallel, 3-Month Safety Study in Adolescent and Adult Patients With Asthma)
Status: Enrolling
Updated: 2/11/2016
North Carolina Clinical Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated:  2/11/2016
West Coast Clinical Trials Global
mi
from
Cypress, CA
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated: 2/11/2016
West Coast Clinical Trials Global
mi
from
Cypress, CA
Click here to add this to my saved trials
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated:  2/11/2016
The Clinical Research Institute of Southern Oregn, PC
mi
from
Medford, OR
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated: 2/11/2016
The Clinical Research Institute of Southern Oregn, PC
mi
from
Medford, OR
Click here to add this to my saved trials
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated:  2/11/2016
Transitional Clinical Research, Inc. Allergy Associates Research Center
mi
from
Portland, OR
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated: 2/11/2016
Transitional Clinical Research, Inc. Allergy Associates Research Center
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated:  2/11/2016
Western Sky Medical
mi
from
El Paso, TX
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated: 2/11/2016
Western Sky Medical
mi
from
El Paso, TX
Click here to add this to my saved trials
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated:  2/11/2016
Sylvana Research Assocaites
mi
from
San Antonio, TX
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated: 2/11/2016
Sylvana Research Assocaites
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated:  2/11/2016
ASTHMA Inc. Clinical Research Center
mi
from
Seattle, WA
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma (A Randomized, Double-Blind, Placebo-Controlled, Crossover, Single Dose Study in 4 - 11 Year Old Children With Asthma)
Status: Enrolling
Updated: 2/11/2016
ASTHMA Inc. Clinical Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
West Coast Clinical Trials
mi
from
Costa Mesa, CA
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
West Coast Clinical Trials
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
Southern California Institute for Respiratory Diseases, Inc.
mi
from
Los Angeles, CA
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
Southern California Institute for Respiratory Diseases, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
Asthma and Allergy Associates of Southern California
mi
from
Mission Viejo, CA
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
Asthma and Allergy Associates of Southern California
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
CHOC PSF, Division of Allergy, Asthma and Immunology
mi
from
Orange, CA
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
CHOC PSF, Division of Allergy, Asthma and Immunology
mi
from
Orange, CA
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
Allergy & Asthma Assocaites of Santa Clara Valley
mi
from
San Jose, CA
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
Allergy & Asthma Assocaites of Santa Clara Valley
mi
from
San Jose, CA
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
Colorado Allergy & Asthma Centers, PC
mi
from
Centennial, CO
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
Colorado Allergy & Asthma Centers, PC
mi
from
Centennial, CO
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
Colorado Allergy and Asthma Centers, PC
mi
from
Denver, CO
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
Colorado Allergy and Asthma Centers, PC
mi
from
Denver, CO
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
Rocky Mountain Center for Clinical Research
mi
from
Wheat Ridge, CO
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
Rocky Mountain Center for Clinical Research
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
Atlanta Allergy & Asthma Clinic
mi
from
Woodstock, GA
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
Atlanta Allergy & Asthma Clinic
mi
from
Woodstock, GA
Click here to add this to my saved trials
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated:  2/11/2016
Iowa Clinical Research Corporation
mi
from
Iowa City, IA
Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Epinephrine Inhalation Aerosol USP, an HFA-MDI: Clinical Study-C For Evaluation Of Efficacy And Safety In Asthma Patients
Status: Enrolling
Updated: 2/11/2016
Iowa Clinical Research Corporation
mi
from
Iowa City, IA
Click here to add this to my saved trials